Jacques Van Dam, M.D., Ph.D.
Academic Appointments
- Member, Stanford Cancer Institute
- Member, Bio-X
Key Documents
Contact Information
- Academic Offices
Alternate Contact Necole Greer Administrative Assistant Email Tel Work 650-736-0431
Professional Overview
Administrative Appointments
- Visiting Scientist, Laser Biomedical Research Center; M.I.T. (2005 - 2010)
- Member, Appointments and Promotions Committee; School of BioEngineering; Stanford University (2005 - 2009)
- Member, Board of Trustees, ASGE Foundation, American Society for Gastrointestinal Endoscopy (2005 - 2009)
Honors and Awards
- President, American Society for Gastrointestinal Endoscopy (2009-2010)
- President, Bockus International Society of Gastroenterology (2005-2007)
- Chair, NIH Advisory Committee, Laser Biomedical Research Center, M.I.T. (2005-2010)
Scientific Focus
Current Research Interests
Dr. Van Dam's research efforts include developing methods for the endoscopic diagnosis and treatment of gastrointestinal cancer. His current research focus involves the application of Raman and light-scattering spectroscopy to endoscopic imaging. Dr. Van Dam is an NIH-funded investigator and the author of more than 300 scientific papers, reviews, and abstracts. He directs Stanfords fellowship in advanced interventional/therapeutic endoscopy. Dr Van Dam is President of the American Society for Gastrointestinal Endoscopy and the immediate Past President of the Bockus International Society of Gastroenterology.
Clinical Trials
- Not Recruiting Safety Study of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
- Not Recruiting Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer
- Not Recruiting Advanced Gastrointestinal Endoscopic Imaging
- Not Recruiting Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer
Publications
- Determination of the relationship between gastric wall thickness and body mass index with endoscopic ultrasound. Obes Surg. 2011; (3): 300-4
- EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy. Gastrointest Endosc. 2010; (3): 513-8
- Pathological response after chemoradiation for T3 rectal cancer. Colorectal Dis. 2010; (7 Online): e24-30
- EUS 2008 Working Group document: evaluation of EUS-guided implantation therapy (with video). Gastrointest Endosc. 2009; (2 Suppl): S49-53
- EUS: state of the art in the USA. Gastrointest Endosc. 2009; (2 Suppl): S217-9
- Election year fever? Voting on EUS criteria for chronic pancreatitis. Gastrointest Endosc. 2009; (7): 1262-3
Help
Trial Administration